查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433458

全球支架技術市場 2023-2030

Global Scaffold Technology Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期（2023-2030年），全球支架技術市場將以10.2%的複合CAGR成長。全球對器官移植、重建手術的需求不斷成長，以及基於 3D 基底的 3D 矩陣設計的研發活動的增加，促進市場成長。細胞間交互作用、高通量掃描、轉染和細胞遷移測定等 3D 培養測定均使用支架技術。此外，血管化和器官植入再生等組織培養應用於損傷和患病器官或組織的治療，也將進一步為支架技術的發展提供潛在機會。

細分市場前景

全球支架技術市場依類型、疾病類型、應用和最終用戶細分。根據類型，市場細分為水凝膠、聚合物支架、微圖案表面微孔板和奈米纖維支架。根據疾病類型，市場細分為骨科、肌肉骨骼和脊椎、癌症、皮膚和外皮、牙科等。根據應用，市場細分為幹細胞治療、再生醫學和組織工程以及藥物開發。此外，根據最終用戶，市場細分為生物技術和製藥組織、研究實驗室和研究所以及醫院和診斷中心。在該類型中，由於水凝膠微加工製程的技術進步預計將在預測期內加速該細分市場的成長，因此預計水凝膠細分市場將佔據相當大的市場佔有率。該公司推出用於細胞移植、藥物儲存和再狹窄屏障的新型水凝膠。例如，2021年3月，Bio-Techne Corporation 宣布推出Cultrex UltiMatrix 減少生長因子基底膜萃取物（RGF BME），這是一種細胞外基質水凝膠，可為培養類器官和多能幹細胞提供顯著的性能和一致性優勢。

幹細胞治療、再生醫學和組織工程細分市場預計將在全球支架技術市場中佔據相當大的佔有率

其中，幹細胞治療、再生醫學和組織工程以及藥物開發細分領域預計將在全球支架技術市場中佔據相當大的佔有率。支架技術在重建手術、美容手術、腹壁修復、牙周病學、軟組織腫瘤修復和大腸直腸治療的應用越來越頻繁。根據國際美容整形外科協會（ISAPS）的資料，2021年整形外科醫生實施的手術總體成長了 19.3%，全球範圍內實施的手術數量超過 1,280 萬例，非手術數量超過 1,750 萬例。移植血液幹細胞是最知名且最常使用的幹細胞治療方法。它可用於治療免疫系統和血液系統疾病，以及在某些癌症治療後修復血液系統。在歐洲，每年約有 26,000 名患者使用血液幹細胞進行治療。

此外，研究人員對支架技術在再生醫學領域的廣泛使用越來越感興趣。例如，2020年 11月，Wake Forest Institute for Regenerative Medicine（WFIRM）的科學家推出了一種可用於軟骨再生的混合組織結構。它是利用 3D 生物列印技術創建的。因此，組織發育研究的不斷擴展可歸因於片段擴展。

目錄

第1章 報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 依地區

第2章 市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第3章 競爭格局

  • 主要公司分析
  • Thermo Fisher Scientific Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Becton, Dickinson and Company
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Merck Group
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第4章 市場細分

  • 依類型分類的全球支架技術市場
    • 水凝膠
    • 聚合物支架
    • 微構形表面微孔板
    • 奈米纖維支架
  • 依疾病類型分類的全球支架技術市場
    • 骨科、肌肉骨骼和脊柱
    • 癌症
    • 皮膚和外皮
    • 牙科
    • 其他（心臟病學和血管學、神經學和泌尿學）
  • 全球支架技術市場（依應用）
    • 幹細胞治療、再生醫學、組織工程
    • 藥物開發
  • 依最終用戶分類的全球支架技術市場
    • 生物技術與製藥組織
    • 研究實驗室和研究所
    • 醫院和診斷中心

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
  • 亞太其他地區
  • 世界其他地區

第6章 公司簡介

  • 3D Biotek, LLC
  • AbbVie Inc.
  • Akron Biotech
  • Avacta Life Sciences Ltd.
  • Avantor, Inc.
  • BICO Group
  • Corning Inc.
  • India Medtronic Pvt Ltd.
  • Lonza Group Ltd.
  • Molecular Matrix, Inc.
  • Nanofiber Solutions, LLC
  • NuVasive, Inc.
  • PELOBIOTECH GmbH
  • REPROCELL
  • Vericel Corp.
Product Code: OMR2028046

Global Scaffold technology Market Size, Share & Trends Analysis Report by Type (Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates and Nanofiber Based Scaffolds),by Disease Type (Orthopedics, Musculoskeletal, & Spine, Cancer, Skin & Integumentary, Dental and Others),by Application (Stem Cell Therapy, Regenerative Medicine,& Tissue Engineering, and Drug Development) and by End-User (Biotechnology & Pharmaceutical Organizations, Research Laboratories & Institutes, Hospitals & Diagnostic Centers)Forecast Period (2023-2030)

The global scaffold technology market is anticipated to grow at a considerable CAGR of 10.2% during the forecast period (2023-2030). The rising demand for organ transplant, reconstruction procedures globally and increase in R&D initiatives on the design of a 3D matrix that is based on 3D substrates is enabling the market growth. 3D culture assays such as cell to cell interactions, high throughput scanning, transfections, and cell migration assays all use scaffold technology. In addition, the tissue culture such as vascularization and organ implant regeneration applied in the treatment of damaged and diseased organs or tissues will further provide potential opportunities for the growth of the scaffold technology

Segmental Outlook

The global scaffold technology market is segmented by the type, disease type, application, and end-user. Based on the type, the market is sub-segmented into hydrogels, polymeric scaffolds, micropatterned surface microplates and nanofiber-based scaffolds. Based on disease type the market is sub-segmented into orthopedics, musculoskeletal, & spine, cancer, skin & integumentary, dental and others. Based on the application, the market is sub-segmented into stem cell therapy, regenerative medicine& tissue engineering, and drug development. Further, based on the end-user, the market is sub-segmented into biotechnology & pharmaceutical organizations, research laboratories & institutes, and hospitals & diagnostic centers. Among the type, the hydrogels sub-segment is anticipated to hold a considerable share of the market owing to technological advancements in microfabrication procedures for hydrogels are anticipated to accelerate the segment growth during the forecast period. Companies are launching new hydrogels for cell transplantation, drug depots, and a barrier against restenosis. For instance, in March, 2021 Bio-Techne Corporation announced the release of Cultrex UltiMatrix Reduced Growth Factor Basement Membrane Extract (RGF BME), an extracellular matrix hydrogel that provides significant performance and consistency benefits for culturing organoids and pluripotent stem cells.

Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering Sub-Segment is Anticipated to Hold a Considerable Share of the Global Scaffold technology Market

Among the application, the stem cell therapy, regenerative medicine & tissue engineering, and drug development sub-segment is expected to hold a considerable share of the global scaffold technology market. Scaffold technology is being utilized increasingly frequently in reconstructive surgeries, aesthetic surgeries, abdominal wall repair, periodontology, soft tissue tumor repair and colorectal treatments. According to the International Society of Aesthetic Plastic Surgery (ISAPS), a 19.3% overall increase in procedures performed by plastic surgeons in 2021 with more than 12.8 million surgical, and 17.5 million non-surgical, procedures performed globally. Transplanting blood stem cells is the most well-known and often used stem cell treatment. It may be used to treat immune system and blood system disorders, as well as to repair the blood system following treatment for certain cancers. Blood stem cells are used to treat around 26,000 patients annually in Europe.

Furthermore, researchers have become increasingly interested in the widespread use of scaffold technologies in the field of regenerative medicine. For instance, in November 2020, Wake Forest Institute for Regenerative Medicine (WFIRM) scientists, introduced a hybrid tissue structure that can be used for cartilage regeneration. It was created with the use of 3D bioprinting technology. As a result, the expanding research into tissue development can be ascribed to segment expansion.

Regional Outlook

The global scaffold technology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to exhibit fastest CAGR during the forecast period. The growing presence of government organizations that conduct regenerative medicine and stem cell research is a key factor driving the regional market growth. India has a vibrant stem cell research ecosystem, with both private and government institutions contributing to the field. For instance, in 2021 financial assistance for stem cell research activities is being provided by the Indian Government. The Government of India has undertaken stem cell research through various Departments/ Institutions, including the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), and Department of Science and Technology (DST). Additionally, increasing public consciousness about the use of organ transplants and increased expenditures in healthcare infrastructure in countries such as India and China also contribute to the regional market's expansion.

North America Expected to Hold Considerable Share in the Global Scaffold technology Market

in the high incidences of cancer, increase in number of organ transplantation, and expansion of biotechnology & pharmaceutical companies is a key factor driving demand for scaffold technology. Growing R&D across the region is further contributing regional market share. For instance, in April 2023, Systemic Bio opened its new lab in Texas, US for hydrogel scaffold manufacturing and research and development activities for organ-on-a-chip technology to enhance drug discovery and development. Disease such as cancer has a major impact in the US. Cancer surgery is a common part of diagnosing and treating cancer. Surgery can show the size of the cancer and whether it has spread, which helps to figure out the cancer's stage. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the US. The most common cancers were breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, and non-Hodgkin lymphoma. Additionally due to presence of major companies including Akron Biotech, 3D Biotek LLC, Thermo Fisher Scientific Inc., Molecular Matrix Inc., Xanofi, and Corning Incorporated is propelling the region's growth.

Market Players Outlook

The major companies serving the scaffold technology market include Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Lonza Group Ltd., 3D Biotek, LLC, Molecular Matrix, Inc., PELOBIOTECH GmbH, India Medtronic Pvt Ltd., Avacta Life Sciences Ltd., AbbVie, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2022, Evonik and BellaSeno, a developer of 3D-printed absorbable scaffolds, were working together to commercialize innovative 3D-printed scaffolds for bone regeneration. The bone scaffolds are made with Evonik's Resomer polymers and are used for large and complex bone defects. Both companies initially began collaborating in 2019 on scaffolds for chest wall and breast reconstruction.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global scaffold technology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Thermo Fisher Scientific Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Becton, Dickinson and Company
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Merck Group
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Scaffold Technology Market by Type
    • 4.1.1. Hydrogels
    • 4.1.2. Polymeric Scaffolds
    • 4.1.3. Micropatterned Surface Microplates
    • 4.1.4. Nanofiber Based Scaffolds
  • 4.2. Global Scaffold Technology Market by Disease Type
    • 4.2.1. Orthopedics, Musculoskeletal, & Spine
    • 4.2.2. Cancer
    • 4.2.3. Skin & Integumentary
    • 4.2.4. Dental
    • 4.2.5. Others (Cardiology & Vascular, Neurology and Urology)
  • 4.3. Global Scaffold Technology Market by Application
    • 4.3.1. Stem Cell Therapy, Regenerative Medicine, Tissue Engineering
    • 4.3.2. Drug Development
  • 4.4. Global Scaffold Technology Market by End-User
    • 4.4.1. Biotechnology & Pharmaceutical Organizations
    • 4.4.2. Research Laboratories & Institutes
    • 4.4.3. Hospitals & Diagnostic Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
  • 5.4. Rest of Asia-Pacific
  • 5.5. Rest of the World

6. Company Profiles

  • 6.1. 3D Biotek, LLC
  • 6.2. AbbVie Inc.
  • 6.3. Akron Biotech
  • 6.4. Avacta Life Sciences Ltd.
  • 6.5. Avantor, Inc.
  • 6.6. BICO Group
  • 6.7. Corning Inc.
  • 6.8. India Medtronic Pvt Ltd.
  • 6.9. Lonza Group Ltd.
  • 6.10. Molecular Matrix, Inc.
  • 6.11. Nanofiber Solutions, LLC
  • 6.12. NuVasive, Inc.
  • 6.13. PELOBIOTECH GmbH
  • 6.14. REPROCELL
  • 6.15. Vericel Corp.

LIST OF TABLES

  • 1. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL HYDROGELSSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL POLYMERIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL MICROPATTERNEDSURFACE MICROPLATESSCAFFOLD TECHNOLOGYMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL NANOFIBER BASED SCAFFOLD TECHNOLOGYMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 7. GLOBAL SCAFFOLD TECHNOLOGY FOR ORTHOPEDICS, MUSCULOSKELETAL, & SPINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL SCAFFOLD TECHNOLOGY FOR CANCERMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SCAFFOLD TECHNOLOGY FOR SKIN & INTEGUMENTARY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SCAFFOLD TECHNOLOGY FOR DENTAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL SCAFFOLD TECHNOLOGY FOR OTHER DISEASEMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 13. GLOBAL SCAFFOLD TECHNOLOGY FOR STEM CELL THERAPY, REGENERATIVE MEDICINE, AND TISSUE ENGINEERINGMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL SCAFFOLD TECHNOLOGY FOR DRUG DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 16. GLOBAL SCAFFOLD TECHNOLOGY FOR BIOTECHNOLOGY & PHARMACEUTICAL ORGANIZATIONSMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL SCAFFOLD TECHNOLOGY FOR RESEARCH LABORATORIES & INSTITUTESMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL SCAFFOLD TECHNOLOGY FOR HOSPITALS & DIAGNOSTIC CENTERSMARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 25. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 26. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 27. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 28. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 29. EUROPEAN SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 30. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 31. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 32. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 33. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 34. ASIA- PACIFIC SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)
  • 35. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 39. REST OF THE WORLD TEST MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL HYDROGELSSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL POLYMERICSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL MICROPATTERNED SURFACE MICROPLATESSCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 5. GLOBAL NANOFIBER BASEDSCAFFOLD TECHNOLOGYMARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY DISEASE TYPE, 2022 VS 2030 (%)
  • 7. GLOBAL SCAFFOLD TECHNOLOGY FOR ORTHOPEDICS, MUSCULOSKELETAL, & SPINE MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL SCAFFOLD TECHNOLOGY FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SCAFFOLD TECHNOLOGY FOR SKIN & INTEGUMENTARY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL SCAFFOLD TECHNOLOGY FOR DENTAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL SCAFFOLD TECHNOLOGY FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022 VS 2030 (%)
  • 13. GLOBAL SCAFFOLD TECHNOLOGY FOR STEM CELL THERAPY, REGENERATIVE MEDICINE, TISSUE ENGINEERINGMARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL SCAFFOLD TECHNOLOGY FOR DRUG DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USERS, 2022 VS 2030 (%)
  • 16. GLOBAL SCAFFOLD TECHNOLOGY FOR BIOTECHNOLOGY & PHARMACEUTICAL ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL SCAFFOLD TECHNOLOGY FORRESEARCH LABORATORIES & INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL SCAFFOLD TECHNOLOGY FOR HOSPITALS & DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 19. GLOBAL SCAFFOLD TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 20. US SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. CANADA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. UK SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. FRANCE SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. GERMANY SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. ITALY SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SPAIN SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF EUROPE SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. INDIA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. CHINA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. JAPAN SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. SOUTH KOREA SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. REST OF ASIA-PACIFIC SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. REST OF THEWORLD SCAFFOLD TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)